Education
About Us
Working with TipRanks
Follow Us
Mindbio Therapeutics Corp. (TSE:MBIO)
:MBIO
MBIO Stock Chart & Stats
C$1.39
>-C$0.01(-20.00%)
At close: 4:00 PM EST
C$1.39
>-C$0.01(-20.00%)
Day’s Range― - ―
52-Week RangeC$0.50 - C$12.50
Previous CloseN/A
Volume53.00K
Average Volume (3M)131.85K
Market Cap
C$2.66M
Enterprise ValueC$6.18M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.68
Next Earnings
Feb 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,044,228
10 Day Avg. Volume111,998
30 Day Avg. Volume131,850
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Mindbio Therapeutics Corp. News
MBIO FAQ
What was Mindbio Therapeutics Corp.’s price range in the past 12 months?
Mindbio Therapeutics Corp. lowest stock price was C$0.50 and its highest was C$12.50 in the past 12 months.
What is Mindbio Therapeutics Corp.’s market cap?
Mindbio Therapeutics Corp.’s market cap is C$2.66M.
When is Mindbio Therapeutics Corp.’s upcoming earnings report date?
Mindbio Therapeutics Corp.’s upcoming earnings report date is Feb 05, 2026 which is in 49 days.
How were Mindbio Therapeutics Corp.’s earnings last quarter?
Currently, no data Available
Is Mindbio Therapeutics Corp. overvalued?
According to Wall Street analysts Mindbio Therapeutics Corp.’s price is currently Overvalued.
Does Mindbio Therapeutics Corp. pay dividends?
Mindbio Therapeutics Corp. does not currently pay dividends.
What is Mindbio Therapeutics Corp.’s EPS estimate?
Mindbio Therapeutics Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mindbio Therapeutics Corp. have?
Mindbio Therapeutics Corp. has 2,044,228 shares outstanding.
What happened to Mindbio Therapeutics Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Mindbio Therapeutics Corp.?
Currently, no hedge funds are holding shares in TSE:MBIO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mindbio Therapeutics Corp.
MindBio Therapeutics Corp. operates as a clinical stage drug development company. It is involved in the clinical research into the microdosing of psychedelic medicines to treat a range of medical conditions, such as depression, anxiety, PTSD, panic disorder, chronic pain, and opiate addictions. The company is based in Melbourne, Australia.
Technical Analysis
Wesana Health Holdings Inc
―
Braxia Scientific
―
HAVN Life Sciences
―
Lexston Life Sciences Corp.
―
―